drugset / Trial / NCT01515917
Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI)
Withdrawn
Deborah Yurgelun-Todd
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a placebo-controlled study intended to examine the effects of the neutraceutical citicholine, together with omega-3 fatty acids, on a range of measures in individuals with concussive head injury, often referred to as traumatic brain injury, or TBI. The study will consist of three visits, during which participants will complete brain scans, a thorough testing battery and a clinical interview to assess mood and other diagnostic information relevant to the study.
Timeline
- Start
- 2013-11
- Primary completion
- 2016-07
- Completion
- 2017-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Citicoline | Other / unclassified | 1000 mg | Oral |
| Subject | Omega-3 fatty acids | Unknown | 2000 mg | Oral |